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ABSTRACT
Although in veterinary medicine the term “Fever of unknown origin” (FUO) is still liberally used for any febrile 
patient where no diagnosis has been set after routine diagnostics, the term “true FUO” should be assigned to those cases 
in which no aetiology is found after extensive diagnostics. The aim of this study was to investigate the occurrence of 
FUO in dogs, to research the structure of the FUO population, as well as to explore clinical signs and their duration, 
and the prior treatment and incidence of different diagnoses and their outcomes. Also, this study was conducted in 
order to explore the amount of diagnostic procedures (with their effectiveness) required to reach a final diagnosis 
with the intention of helping design and prioritize diagnostics of FUO in dogs in Croatia. Final diagnosis was reached 
in 94% (47/50) of dogs with a total of 626 diagnostic procedures used. Immune-mediated diseases occurred most 
frequently (56%), followed by infectious diseases (24%), neoplastic diseases (10%) and congenital diseases (4%), 
with only 6% of “true FUO”. Body temperature ranged between 39.6 °C and 42.0 °C. The most common symptoms 
were nonspecific (anorexia and lethargy in 88%, pain in 78%, and gait disorders in 60%). The most frequent test 
performed was hematology while hemoculture was performed the least. Cytology and/or pathohistology were the 
most effective tests in achieving the final diagnosis (76.32%). The duration of clinical signs before the diagnosis/
proper treatment was 4-1825 days. The outcome was favorable in 62%, unfavorable in 32% and unknown in 6%. 
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undergo a proper and thorough diagnostic workup, 
the percentage of patients with no underlying cause 
of fever should be relatively low.
In human medicine, FUO was defined for the 
first time in 1961 as a fever over 38.3 °C that lasts 
for more than three weeks without certain diagnosis 
found after 1 week of hospital investigation 
Introduction
Fever of unknown origin (FUO) represents 
a considerable clinical challenge in both human 
and veterinary medicine. However, it should be 
emphasized that the term FUO is certainly over-
used in veterinary medicine, with too many cases 
of febrile patients incorrectly and prematurely 
classified as having FUO, meaning that if they 
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(PETERSDORF and BEESON, 1961). Later, 
this definition was modified in order to include 
outpatients or inpatients with hospital investigation 
of a duration of at least 3 days (DURACK and 
STREET, 1991). 
In veterinary medicine, FUO is still not strictly 
defined, and there are no specific criteria for 
patient classification in the FUO category. Still, 
FUO in dogs is usually described as a fever higher 
than 39.7 °C to 40.0 °C, with no specific duration 
(DUNN and DUNN, 1998; BATTERSBY et al., 
2006). Generally, in the relevant veterinary small 
animal internal medicine textbooks, contemporary 
definitions of FUO vary greatly from the very 
liberal as a “febrile syndrome for which a diagnosis 
is not evident” (COUTO, 2014) to the strict and 
detailed as a “body temperature higher than 39.2 
°C with duration of at least three weeks in which no 
obvious cause is apparent, following at least 3 visits 
to the veterinarian and/or 3 days of hospitalization, 
including a basic evaluation of history, clinical 
examination and minimal diagnostic testing 
(complete blood count (CBC), serum biochemistry 
profile and urinalysis)” (RAMSEY i TASKER, 
2017). It has been established that fever can be 
caused by more than 200 diseases in humans 
(KNOCKAERT et al., 2003). Since a large number 
of diseases can also cause fever in dogs, the 
identification of its cause requires a thorough, logical 
and consistent plan, which should be individually 
created for each patient, considering the etiology of 
the fever, clinical signs, the frequency of different 
pathologies, CBC, biochemistry, urinalysis, 
radiography and deliberate selection of different 
diagnostic tests. 
When dealing with a patient that has elevated 
body temperature, the distinction between fever 
and hyperthermia is of utmost importance. Whilst 
fever is an elevation in body temperature resulting 
from a change in the thermoregulatory center, 
hyperthermia is elevated body temperature resulting 
from outside causes (i.e. anxiety, environmental 
conditions, exercise).





abscesses (i.e. prostic, liver, tooth root), pyothorax, pyometra, osteomyelitis, 
prostatitis, 
discospondylitis, pyothorax, osteomyelitis, cholangitis, septic arthritis, 
bacterial endocarditis
other: anaplasmosis, boreliosis, leptospirosis, erlichiosis
Viral infections
canine distemper virus, adenovirus, parvovirus, influenza virus
Fungal infections




Immune-mediated hemolytic anemia, thrombocytopenia, polyarthritits, 
polymyositis, steroid-responsive meningitis arteritis, vasculitis, nodular 
panniculitis, trapped neutrophil syndrome, polysystemic immune-mediated 
diseases (i.e. systemic lupus erythematosus)
Inflammatory (non-infectious) 
diseases Juvenile cellulitis, myositis, pancreatitis/sterile pancreatic abscesses
Neoplastic diseases
Lymphoproliferative diseases (i.e. leukemia, lymphomas, multiple myeloma), 
myeloproliferative diseases, solid tumors, Sertoli cell tumors, lung tumors, 
metastatic diseases, any necrotic or infected tumor
Miscellaneous diseases Idiosyncratic reactions to drugs (especially sulfonamides) or vaccines, metaphyseal osteopathy, panosteitis
Fever of unknown origin Unknown etiology after routine or extensive diagnostics
Modified from: Causes of fever in dogs and cats. (Ramsey and Tasker, 2017) 
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The vast majority of causes of fever can be 
classified as infectious, immune-mediated or 
neoplastic (Table 1), among which some are difficult 
to recognize as well as to diagnose without specific 
tests due to the nonspecific or even hidden signs 
(i.e. discospondylitis, steroid responsive meningitis 
arteritis (SRMA), immune-mediated polyarthritis 
(IMPA), infectious endocarditis). Some diseases 
occur more frequently in certain breeds (i.e. 
SRMA in Beagles and Bernese mountain dogs, 
immune mediated hemolytic anemia (IMHA) 
in English cocker spaniels). Furthermore, the 
patient's travel history should never be neglected 
(vector borne diseases (VBD) i.e. leishmaniosis). 
More specifically, in Croatia many VBDs have 
been confirmed in dogs (babesiosis, borelliosis, 
anaplasmosis, leishmaniosis, dirofilariosis, 
hepatozoonosis), some of which are geographically 
restricted and thus characterized as endemic (i.e. 
babesiosis in continental parts or leishmaniosis in 
Dalmatia) (ŽIVIČNJAK et al., 2005; BRKLJAČIĆ 
et al., 2010; DEŽĐEK et al., 2010; MRLJAK et 
al., 2017; JURKOVIĆ et al., 2019). Also, data 
about previous diseases, prior treatments and the 
response to those treatments should be collected. 
A thorough physical examination can direct the 
clinician towards a diagnosis, as well as serving 
as guidance in choosing further diagnostic tests 
(i.e. aspiration of enlarged lymph nodes). Physical 
examination must include orthopedic, neurological 
and ophthalmological assessment, as well as oral, 
otic and digital rectal examination.
Previous studies in dogs presenting with pyrexia 
have demonstrated that the most common cause 
of pyrexia were immune-mediated disorders (22% 
DUNN and DUNN, 1998; 34.8% BATERSBY et 
al., 2006; >50% BLACK et al., 2018). Infectious 
diseases are a significantly less frequent cause of 
FUO in dogs (16% DUNN and DUNN, 1998; 27.3% 
BATTERSBY et al., 2006; 17,9% BLACK et al., 
2018). Contrary to these findings, the occurrence of 
infections as a cause of FUO in human medicine is 
much more common: 51% in children and 35% in 
adults (CHOW and ROBINSON, 2011; CHUSID, 
2017).
The aim of this study was to investigate the 
occurrence of FUO in dogs, as well as to describe 
the structure of the FUO population (age, breed, 
gender). Furthermore, this study was designed 
with the purpose of exploring the clinical signs 
and their duration, prior treatment, the incidence 
of different diseases causing FUO in dogs, and 
finally, the outcome. Moreover, we investigated 
the effectiveness of various diagnostic tests in 
reaching the final diagnosis, in order to improve the 
diagnostic approach to FUO in dogs in Croatia. 
Materials and methods
Animals. Among 5768 records of fever in 
dogs admitted to the Clinic for Internal Medicine, 
Veterinary Faculty, University of Zagreb, in the 
period between January 2006 and July 2019, 50 
dogs met the following inclusion criteria:
body temperature ≥39.6 °C for at least 3 days
complete history data including previous 
treatments (if treated)




owner-signed informed consent (for diagnostic 
and treatment procedures)
unknown diagnosis after initial workup.
Exclusion criteria were:
owner’s refusal of recommended diagnostics
any chronic/systemic disease previously diagnosed
Regarding the age at admission, each patient 
was categorized into one of the following groups: 
juvenile (2-18 months), young (19-48 months), 
middle-aged (49-84 months) or older (85-128 
months) (Table 4).
Diagnostics. In order to determine the impact 
of diagnostics in reaching the final diagnosis, 
each of the following diagnostic procedures: 
CBC, biochemistry, urinalysis, cytology and/
or pathohistology (PHD), as well as radiography, 
ultrasound, bacteriology, hemoculture and specific 
tests (Table 5), was considered as a single test and 
further classified as: 1) determinant for diagnosis, 
2) helpful for diagnosis or 3) meaningless.
Haematology was performed using an ABC 
Automated Hematology Analyser (Horiba 
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Diagnostics, Montpellier, France) and serum 
biochemistry using an Olympus AU 640 Analyser 
(Olympus Diagnostica GmBH, Hamburg, 
Germany). Thoracic and abdominal radiography 
was performed using an Eickermeyer EDR HP 
(IMD Generators s. r. l., Italy) with digital data 
processing and image distribution by Agfa CR 30-X 
(Agfa, Japan). Ultrasound was performed using s 
MyLabTM 40Vetusing a 8-6 mHz microconvex 
ultrasound transducer (Esaote, Italy).
Synovial and cerebrospinal fluid (CSF) 
sampling, as well as fine needle aspiration (FNA) 
of abdominal lymph nodes and parenchymal 
organs were performed under general anesthesia 
followed by bacteriology and/or cytology, PHD/
immunocytochemistry. Interpretation of results was 
done by board certified specialists. Hemoculture 
and specific tests were performed in external, 
veterinary accredited laboratories: SYNLAB, 
Munich, Germany and LABOKLIN, Bad Kissingen, 
Germany.
Testing for VBD was performed using Idexx 
SNAP 4Dx Plus Test (Idexx Laboratories, Inc., 
Westbrook, USA), followed by PCR diagnostic in 
all samples that tested positive.
All the confirmed diagnoses were divided into 
five groups, namely: (1) immune-mediated diseases 
(IMD), (2) infectious diseases (ID), (3) neoplastic 
diseases (ND), (4) congenital diseases (CD) and (5) 
FUO (“true FUO”) groups (Table 3). 
Statistical analysis. All exploratory and 
statistical data analyses were performed using 
R software ver. 3.6.0 (R Core Team, 2019). A 
language and environment for statistical computing. 
R Foundation for Statistical Computing, Vienna, 
Austria. URL https://www.R-project.org/). The 
dependent variable of interest was the disease 
type (immune-mediated, infectious, neoplastic, 
congenital, and FUO). The independent variables 
of interest were demographic (breed, gender, 
age), anamnestic (clinical symptoms, duration 
of symptoms, time taken to reach a diagnosis, 
outcome), and diagnostic test data (hematological 
and biochemical). Categorical variables were 
tested for associations using Fisher's exact test 
for 2×2 contingency tables, while for lager tables 
the pairwise nominal independence test was used. 
Numerical variables (diagnostic test data) were 
analyzed using linear regression for association 
with disease type. The association of breeds with 
FUO diagnosis was tested using the exact binomial 
test, with the null hypothesis of the probability of 
a certain breed’s proportion in the FUO population 
being equal to its proportion in the hospital 
population.
Results
Cases. Among all records of dogs that presented 
with fever (n = 5768) a total of fifty dogs met 
the inclusion criteria. Twenty-five breeds were 
represented in the investigated group, and 24% 
were mixed breed (Table 2). The age range was 
2-128 months (mean 43 ± 66.1) (Table 3). There 
were 18 (36%) juvenile, 14 (28%) young, 12 (24%) 
middle-aged and 6 (12%) older dogs (Table 4). In all 
age groups, IMD was the most frequent diagnosis 
(Table 4) whereas ID was the second most frequent 
diagnosis, except in the middle-aged group in 
which ND was twice as frequent as ID (Table 4). 
The investigated population consisted of 23 females 
and 27 males (Table 3). Body temperature ranged 
between 39.6 °C and 42.0 °C (40 ± 1.06) (Table 
3). The most common symptoms at admission 
were nonspecific signs such as general symptoms 
(loss of appetite/anorexia, lethargy) in 88% and 
pain in 78%, followed by gait disorders (lameness, 
stiffness, painful joints) in 60% of dogs (Table 3).
Diagnostics. Final diagnosis was established 
in 47 dogs (94%) with a total of 626 diagnostic 
procedures used (mean: 12.5 per patient) (Table 5). 
The most frequent were IMD (56%) followed by ID 
in 24%, ND in 10% and CD in 4%. The remaining 
3 cases (6%), in which the underlying disease was 
not revealed despite extensive diagnostics, were 
classified as FUO (“true FUO”). Among dogs 
with IMD (n = 28), the most frequent diagnosis 
was SRMA (32.1%), whereas in 2 dogs (7.1%) 
exact diagnosis was not reached despite thorough 
diagnostics workup, so they were subjected to 
owner-consented corticosteroid therapy to which 
they both responded well and thus were categorized 
as “undefined IMD”. In the group with ID, VBD 
and sepsis were equally represented. 
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All the diagnoses and their frequencies are 
shown in Table 3. The frequency of procedures 
used and their effectiveness in reaching the 
final diagnosis are shown in Table 5. The most 
frequent test performed was CBC, while the least 
frequently used was hemoculture. Almost all the 
tests performed contributed to reaching a diagnosis 
(either by directing towards, confirming or 
excluding differentials) except hemoculture, which 
was performed in just 3 cases and was not helpful 
in any (because a negative result does not exclude 
infection/sepsis). Cytology and/or PHD were the 
most effective tests in achieving the final diagnosis 
(76.32%).
















Alaskan malamute 0.55 2 8.33 0 0 0 0
American Stafford 2.47 4 8.33 0 0 0 3.57
australian shepherd 0.01 2 0 50 0 0 0
Balkan hound 0.02 2 0 0 0 0 3.57
Basset 0.11 2 8.33 0 0 0 0
Beagle 0.95 6 0 0 0 0 10.71
Bernese mountain dog 0.82 4 0 0 0 20 3.57
Bischon frise 0.53 2 0 0 0 0 3.57
Border collie 0.35 2 0 50 0 0 0
Boxer 1.66 4 0 0 0 0 7.14
Cane corso 0.44 2 0 0 0 0 3.57
Chow chow 0.19 2 8.33 0 0 0 0
English setter 0.2 2 8.33 0 0 0 0
german shepherd 4.11 10 8.33 0 0 0 14.29
Golden retriever 3.54 4 0 0 0 20 3.57
Great Dane 0.39 2 0 0 0 0 3.57
greyhound 0,03 2 0 0 0 0 3.57
Labrador retriever 5.38 6 16.67 0 0 0 3.57
Maltese 5.04 2 0 0 0 0 3.57
Miniature schnauzer 1.06 2 0 0 0 0 3.57
puli 0.08 2 0 0 0 0 3.57
Samoyed 0.77 2 0 0 0 20 0
Siberian husky 0.65 2 8.33 0 0 0
Tornjak  
(Bosnian and Herzegovinian - 
Croatian shepherd dog)
0.49 4 0 0 0 0 7.14
Weimaraner 0.23 2 0 0 0 0 3.57
Mixed breed 27.22 24 25 0 100 40 14.29
ID-infectious diseases, CD-congenital diseases, ND-neoplastic diseases, IMD-immune-mediated diseases, *HP-overall hospital population of dogs 
admitted at the Clinic for Internal Diseases, Veterinary Faculty, University of Zagreb, in the period between January 2006 and July 2019, **IP-
investigated population (n = 50), ***tFUO-”true FUO”- fever of unknown origin (dogs with no diagnosis established despite extensive diagnostics). 
Breeds that are pointed out in bold are breeds that are overrepresented in the investigated population compared to the hospital population (P<0.01)
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Table 4. Age distribution in the investigated population
Age group 
(months)
Juvenile (2-18) Young (19-48) Middle age (49-84) Older (85-128)
n % n % n % n %
IMD 11 61.1 8 57.14 5 41.67 4 66.67
ID 4 22 5 35.72 2 16.67 1 16.67
ND 0 0 0 0 4 33.3 1 16.67
CD 2 11 0 0 0 0 0 0
tFUO 1 5.56 1 7.14 1 8.33 0 0
Total 18 36 14 28 12 24 6 12
IMD-immune-mediated diseases, ID-infectious diseases, ND-neoplastic diseases, CD-congenital diseases, tFUO -”true FUO”: 
fever of unknown origin (dogs with no diagnosis established despite extensive diagnostics), n-number of dogs
Table 5. Effectiveness of diagnostic procedures in the investigated population
Diagnostic procedure
Total number of 
procedures performed
Number of procedures 
that confirmed the final 
diagnosis
Portion of procedures 
that confirmed the final 
diagnosis (%)
Hematology 222 3 1.35
Biochemistry 196 0 0
Urinalysis 20 0 0
Radiography 39 2 5.13
Ultrasound 25 6 24
Cytology (and/or pathohistology) 38 29 76.32
Bacteriology/culture 20 0 0
Hemoculture 3 0 0
Specific 
tests
4DX 21 1 4.8
Leptospirosis 8 0 0
Leishmaniosis 7 3 42.86
PCR - GI Viruses and VBD 15 2 13.33
ANA 8 5 62.5
RF 4 0 0
Total 626 51* 
GI-gastrointestinal, VBD-vector-borne diseases, ANA-antinuclear antibodies, RF-rheumatoid factor; *in some cases the diagnosis 
was established by a combination of two diagnostic tests
Tests results. Hematology and biochemistry 
results are shown in Figs. 1-11. Considering packed 
cell volume (PCV), mean values in four out of five 
disease groups were below the reference range. 
The mean value of PCV was only in the reference 
range in neoplastic diseases (Fig. 2). The mean 
values of white blood cell count (WBC), segmented 
neutrophils percentage and non-segmented (band) 
neutrophils percentage were above the reference 
range in all disease groups, except congenital 
diseases, in which these values were far below the 
reference range (Fig. 4). In contrast, the lymphocyte 
percentage was below the reference range in all 
groups, except congenital diseases, in which it was 
extremely high (Figs. 5-7). 
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Fig. 2. Packed cell volume in the investigated 
population (the area between dashed lines represents the 
reference range)
Fig. 1. Red blood cell count in the investigated 
population (the area between dashed lines represents the 
reference range)
Fig. 4. White blood cell count in the investigated 
population (the area between dashed lines represents the 
reference range)
Fig. 3. Platelet count in the investigated population (the 
area between dashed lines represents reference the range)
Fig. 6. Percentage of non-segmented neutrophils in the 
investigated population (the area between dashed lines 
represents the reference range)
Fig. 5. Percentage of segmented neutrophils in the 
investigated population (area between dashed lines 
represents the reference range)
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Fig. 9. Total protein concentration in the investigated 
population (the area between dashed lines represents the 
reference range) 
There was no statistically significant difference 
between disease groups in any of the investigated 
hematology (Figs. 1-7) or biochemistry (Figs. 
8-11) parameters. However, the concentration 
of C-reactive protein (CRP) was appropriately 
increased in all fifty cases (Fig. 8).
Duration of symptoms. The duration of clinical 
signs until the diagnosis/proper treatment was 
4-1825 (33 ± 590.75) days, with the longest 
duration for undefined IMD (772-1825; mean 
1298.5 ± 1053) (Table 3).
Previous treatment. Only three dogs (6%) 
did not receive any antibiotic treatment before 
admission, while the vast majority (72%) received 
Fig. 11. Globulin concentration in the investigated 
population (the area between dashed lines represents 
the reference range)
Fig. 7. Percentage of lymphocytes in the investigated 
population (the area between dashed lines represents the 
reference range)
Fig. 8. C-reactive protein concentration in the 
investigated population (the area between dashed lines 
represents the reference range)
Fig. 10. Albumin concentration in the investigated 
population (the area between dashed lines represents the 
reference range)
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several different antibiotics. Non-steroidal anti-
inflammatory drugs (NSAIDs) were administered 
in 36% of dogs before admission. The majority 
of dogs received different types of supportive 
treatment before admission (i.e. fluid therapy, 
vitamins, gastric protectants etc.).
Outcome. The outcome was favorable in 62%, 
unfavorable in 32% and unknown in 6% of all 
cases. The most favorable outcome was noted in 
IMD (75%), and the least favorable in ND (20%) 
(Table 3).
Discussion
Since dealing with FUO is extremely time (and 
money) consuming for both the clinician and the 
owner, and often life threatening for the patient, 
thus involving a large amount of frustration, the 
main goal in handling FUO is to convert “FUO” 
into a definitive diagnosis, while minimizing 
expense, the invasiveness of diagnostics and the 
patient’s discomfort. 
In human medicine, FUO is strictly defined as a 
fever ≥38.3 °C that lasts for 3 weeks or more that 
remains undiagnosed after 3 days of in-hospital 
testing, or during two or more outpatient visits 
(PETERSDORF and BEESON, 1961; DURACK 
and STREET, 1991) while in veterinary medicine 
FUO is still loosely defined and in a “grey zone”. 
FUO in dogs is usually described as a fever higher 
than 39.7 °C, up to 40.0 °C, with no specific duration 
(DUNN and DUNN, 1998; BATTERSBY et al., 
2006) or with various different durations (RAMSEY 
and TASKER, 2017). A large number of diseases 
can cause fever in humans (KNOCKAERT et al., 
2003) as well as in dogs, so the identification of its 
cause requires a thorough, logical and consistent 
diagnostic approach to each patient. 
Fifty dogs met the inclusion criteria among 
which three remained undiagnosed at the end of 
investigation (“true FUO”). Compared to other 
studies (19% in the study by DUNN and DUNN, 
1998; 22.7% in the study by BATTERSBY et al., 
2006; 28% in the study by CHERVIER et al., 2012; 
and 17.9% in the study by BLACK et al., 2018), 
the lower percentage (6%) of “true FUO” dogs in 
this study is most probably the result of a different 
diagnostic approach. Therefore, these results should 
be compared with caution, considering the fact that 
in the aforementioned studies, the undiagnosed 
dogs were not actually dogs with “true FUO”, but 
rather dogs without definitive diagnosis in which 
the fever resolved either spontaneously or, in the 
vast majority of cases, after empirical treatment 
(antibiotics/NSAIDs/steroids). For example, in 
the study performed by BLACK et al. (2018) 
25/115 dogs were undiagnosed, with 24/25 dogs 
successfully treated with corticosteroids, among 
which 21 dogs were treated under the provisional 
diagnosis of SRMA based only on clinical signs 
and signalment, and one dog was euthanized before 
the diagnosis was made. These 24 or 25 dogs 
should not be considered either as “true FUO” or 
as SRMA. Also, the authors stated that in these 
24 dogs, “pyrexia resolved before investigations 
were completed”, which is controversial regarding 
the empirical use of corticosteroids. In the study 
by BATERSBY et al. (2006) in 22.7% (15 dogs) 
diagnosis could not be made, and in 7 of these, 
trial therapy was initiated, in 7 the fever resolved 
spontaneously (5 of these dogs had received 
treatment within 24 hours prior to referral) and in 1 
dog the owner refused the diagnostics. CHERVIER 
et al. (2012) conducted a study in which in 14/50 
dogs diagnosis was not made, but it should be noted 
that in 13/14 dogs the owners refused diagnostics. 
Finally, to conclude, the difference in the number 
of undiagnosed patients in this study compared to 
other studies lies in a fact that the owner's refusal 
of extensive diagnostic workup and fever resolution 
due to treatment trial before pursuing extensive 
diagnostics were exclusion criteria in our study. 
On the basis of the final diagnosis, 47 (94%) 
dogs in our study were classified as having IMD, 
ID, ND or CD. Considering the above-mentioned 
discrepancies, when omitting the percentage of 
“true FUO”, the proportion of cases in all four 
remaining groups was similar to other studies (the 
most frequent cause of fever was IMD followed by 
fever caused by ID and neoplasms, respectively). 
Since most of the studies showed that IMDs have 
an incidence at least twice as high as ID, empirical/
trial treatment with antibiotics (previously 
recommended and frequently used) (COUTO, 
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2014) should not be the treatment of choice in 
FUO patients. The most frequently diagnosed 
disease in this study was SRMA (18%), which is 
in accordance with most other studies investigating 
pyrexia in dogs (BATERSBY et al., 2006; 
BLACK and al., 2018). The consistency in SRMA 
prevalence among different studies of pyrexia in 
dogs is not unexpected considering the fact that 
the odds of SRMA development are breed-related 
but not associated with geographical, demographic, 
social or environmental factors (ROSE et al., 
2014). Also, as in other studies, IMPA (12% in this 
study) is the second most frequent disease observed 
(BATERSBY et al., 2006; BLACK and al., 2018).
Regarding IDs, we categorized them into 2 
groups: 1) systemic/septic infections and 2) VBD. 
Many bacterial and fungal infections can be hidden 
due to occult localization and therefore are both 
hard to diagnose and treat properly because their 
causative agents are not sensitive to the standard, 
commonly used empirical antibiotic therapy. 
Therefore, it is not surprising that these patients will 
have fever until extensive diagnostics are performed 
and both localization and microorganisms are 
recognized. Vector borne diseases are related to 
geographical and environmental factors, and their 
treatment also includes specific drugs not commonly 
used in general veterinary practice. While in human 
medicine IDs represent the vast majority of FUO 
cases in children (CHUSID, 2017), in dogs ID 
are much less reported as the cause of FUO than 
IMD. The occurrence of ND in human medicine is 
much more frequent than in veterinary medicine 
(ARMENTANO, 2016). Fever in these cases can 
be part of a paraneoplastic syndrome, as well as 
a consequence of various complications related to 
ND. In this study we detected 10% of ND causing 
FUO. Since pancreatic tumors are one of the rarest 
tumors in dogs, it was surprising that 3/5 cases due 
to ND were of pancreatic origin. This indicates that 
pancreatic tumors could cause fever with higher 
frequency than other neoplasms. The low incidence 
of CD in dogs with FUO in this study (4%) and 
other similar studies (2.9% in the study by BLACK 
et al., 2018) was expected, due to the fact that CDs 
are rare, as well as breed and genotype dependent. 
The age distribution was wide (2-128 months; 
mean 3.6 years) but juvenile and young dogs 
prevailed (64%) (Table 4). These data are similar to 
other published data regarding fever in dogs (mean: 
4.6 years in the study by DUNN and DUNN, 1998; 
3.1 years in the study by BATTERSBY et al., 2006; 
and 2.25 years in the study by CHERVIER et al., 
2012). The prevalence of IMD, followed by ID in 
almost all age groups (Tables 3 and 4) was also noted 
in other studies. The predomination of young dogs 
having FUO is not unexpected due to the fact that a 
large number of IMDs and almost all CDs usually 
occur early in life. Furthermore, it is a well-known 
fact that IDs are much more common in younger 
populations, which can be explained by immune 
status development. The only difference considering 
the distribution of diagnoses between age groups is 
that in our study NDs were most common in middle 
aged dogs, while in the study by DUNN and DUNN 
(1998) the incidence of ND was highest in the older 
group. There was no significant gender prevalence, 
which is in agreement with the data previously 
published (DUNN and DUNN, 1998; BATTERSBY 
et al., 2006; CHERVIER et al., 2012). Australian 
Shepherd, Basset, Beagle, Bernese Mountain Dog, 
Chow Chow, English Setter, German Shepherd, 
Greyhound, Puli and Tornjak were breeds that were 
overrepresented in the investigated population 
compared to the hospital population (Table 2). One 
should be cautious when interpreting these results 
since some breeds are extremely rare in the hospital 
population (i. e. Australian Shepherd, Basset, Chow 
Chow, English Setter, Greyhound, Puli and Tornjak 
- all below 0.2% of the hospital population) while 
the predominance of more popular breeds (i. e. 
German Shepherd, Beagle and Bernese Mountain 
Dog) in the FUO population represents a more 
reliable result. This is not surprising because all of 
these three breeds are prone to develop IMD (i.e. 
Beagles and Bernese Mountain Dog for SRMA and 
German Shepherd for IMPA) (ROSE et al., 2014; 
DUNN and DUNN, 1998). 
One of the main problems in diagnosing the 
underlying cause of FUO is the non-specificity of 
the clinical presentation, which was also the case 
in the present study. However, the high percentage 
of gait disorders and/or pain (especially neck pain) 
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should be tested for a congenital disease. As in other 
reports (CHERVIER et al., 2012), cytology and/or 
PHD had the highest, while bacteriology (Table 5) 
the lowest percentage of success. This data are not 
surprising due to the fact that FNA is performed 
when there is an objective indication (revealed 
by other procedures), while bacteriology is most 
often done in order to exclude bacterial infection 
(i.e. bacteriological examination of CSF to exclude 
bacterial meningitis prior to corticosteroid treatment 
for SRMA). Also, the relatively high proportion of 
effectiveness of specific tests in confirming the final 
diagnosis is partly on account of their prudential 
application. Finally, since there is no diagnostic 
gold standard for FUO, there is no better way of 
managing FUO than by using the already proven 
multistage approach: initial diagnostics followed 
by a systematic, rational and objective choice of 
additional diagnostic procedures. This type of 
approach unfortunately results in the use of a large 
number of different tests for each patient, but has 
the highest odds for making a final diagnosis, and 
contributes to the patient’s welfare.
Conclusion
In conclusion, FUO still remains a real challenge 
in veterinary medicine regarding the unclear 
definition and failure in recognizing and treating 
the underlying disease. This is also supported by the 
results of our study considering the long duration 
of symptoms and unsuccessful prior treatments. 
The long duration of clinical signs in numerous 
cases (the longest duration being 1825 days), 
during which patients were treated with numerous 
antibiotics, NSAIDs and other futile (inefficient) 
treatments, showed that veterinary practitioners 
still neither understand the concept of FUO (which 
should better be termed as fever of origin yet to be 
discovered) nor follow the diagnostic guidelines. 
Since only 24% of FUOs were due to ID (among 
which half were due to VBD, thus requiring specific 
treatment) it is obvious that treating a FUO patient 
with broad-spectrum antibiotics, in the best case 
scenario, would be efficient in only 12% of cases in 
this study. On the other hand, despite the fact that 
most recent studies have confirmed that the majority 
of FUO are caused by IMD, a trial treatment with 
in young dogs with fever should raise the suspicion 
of IMD (i.e. SRMA, IMPA) (Table 3). The high 
frequency of SRMA and IMPA cases in studies of 
pyrexia/FUO in dogs could also be attributed to 
the reluctance of general veterinary practitioners 
to perform certain diagnostic procedures, such as 
CSF or synovial fluid sampling, which results in the 
clustering of these patients within referral centers. 
Since there is no accepted strict definition 
of FUO in veterinary medicine, FUO is usually 
declared in any febrile patient that has not been 
diagnosed after performing routine diagnostic tests, 
where the term “routine” is highly variable between 
different authors. Consequently, diagnostic workup 
is usually long lasting and unpredictable, making the 
owners dubious and frustrated. Still, an individual, 
thorough approach in each FUO patient (based 
on history, clinical examination, and different 
diagnostic procedures depending on most probable 
differentials, as well as on numerous reevaluations) 
is worthwhile in most cases. Nevertheless, this study 
also showed that an average of 12.5 tests per patient 
was necessary to determine a final diagnosis. Most 
authors agree that the aforementioned initial workup 
in febrile patients should include a thorough history, 
clinical examination, CBC, biochemistry, urinalysis 
and radiography, which already represents 5 (basic) 
procedures, rarely sufficient in reaching a diagnosis. 
Anyhow, although rarely diagnostic, these tests 
should not be neglected because they direct the 
clinician towards further diagnostic procedures that 
should follow. This was also confirmed in this study. 
For example, radiography was crucial in reaching 
an exact diagnosis in just two cases (diagnostic 
success 5.1%) of discospondylitis (Table 5) while 
cytology and/or PHD were crucial in 27 cases 
(diagnostic success 76.32%) (Table 5). However, 
radiography frequently revealed the site that 
should be sampled for cytology/PHD (i.e. IMPA, 
pyothorax, lymphoma). Likewise, although there 
were no significant differences in hematological 
parameters between disease groups, specific patterns 
could be used as guidelines towards diagnosis. 
For example, a patient with marked leukopenia 
combined with neutrophil percentage (segmented 
and non-segmented) below the reference range, and 
lymphocyte percentage above the reference range, 
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corticosteroids, before pursuing diagnostics, would 
seriously compromise patient welfare (or may 
even cause death) in 24% of patients in this study. 
Giving corticosteroids without excluding a possible 
infection, also compromises the patient’s welfare 
and is in direct opposition to the fundamental 
principle of medicine: “First, do no harm.” Since 
trial/empirical treatment in many cases showed 
that it is at least useless if not harmful, as well as 
prolonging the time to diagnosis, it is strongly not 
recommended in FUO patients (ARMENTANO, 
2016). To summarize, the general approach to FUO 
patient should always be supported by awareness 
that in most cases the etiology of FUO is not a rare 
disease but rather a common disease presenting in a 
nonspecific or atypical fashion.
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SaŽEtaK
Premda termin vrućica nepoznatog uzroka (VNU) u veterinarskoj medicini još uvijek nema točno određenu 
definiciju ni kriterije klasifikacije, te se vrlo često liberalno upotrebljava u febrilnih pacijenata u kojih nije postavljena 
egzaktna dijagnoza nakon rutinske dijagnostičke obrade, VNU bi trebalo rezervirati za one pacijente u kojih ni nakon 
opsežne dijagnostike nije otkriven uzrok, tj. postavljena konačna dijagnoza. Ciljevi ovog istraživanja bili su istražiti 
pojavnost VNU-a kao i različitih dijagnoza u pasa s vrućicom, kliničke simptome i njihovo trajanje do postavljanja 
dijagnoze i početka ciljanog liječenja, te ishode liječenja, odnosno bolesti. Također, svrha ovog istraživanja bila je 
istražiti prosječan broj dijagnostičkih postupaka (i njihovu učinkovitost) potrebnih za postavljanje konačne dijagnoze, 
s ciljem kreiranja dijagnostičkog plana u pasa s VNU-om u Hrvatskoj. U 94 % pasa (47/50) postavljena je konačna 
dijagnoza pomoću ukupno 626 dijagnostičkih postupaka. Najčešće su bile zastupljene imunosno posredovane bolesti 
(56 %), zatim infekcijske (24 %), neoplastične (10 %) i kongenitalne (4 %), dok je pravi VNU bio zastupljen u samo 
6 % slučajeva. Tjelesna temperatura kretala se od 39,6 do 42,0 °C. Najčešći su klinički znakovi bili nespecifični 
(gubitak apetita i letargija u 88 %, bolnost u 78 % te poremećaji kretanja u 60 % slučajeva). Najčešći je dijagnostički 
postupak bila hematološka pretraga, a najrjeđi hemokultura. Citološka i/ili patohistološka pretraga pokazale su se 
najučinkovitijima u postavljanju konačne dijagnoze (76,32 %). Trajanje simptoma do postavljanja dijagnoze, odnosno 
početka adekvatnog liječenja iznosilo je od 4 do 1825 dana. Ishod je u 62 % pasa bio povoljan, u 32 % nepovoljan, 
dok je u 6 % ostao nepoznat.
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